The mycoplasma plate antigens market is projected to grow from USD 589.9 million in 2025 to USD 1,056.5 million by 2035, at a CAGR of 6.0%. Plate Agglutination Mycoplasma Plate Antigen Test Products will dominate with a 54.8% market share, while for drug development will lead the application type segment with a 41.2% share.